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INTRODUCTION
An  estimated  4,70,000  new  cases  of  cervical  cancer  are 
diagnosed each year worldwide. 80% of these occur in developed 
countries.
A quarter of the global burden is experienced in India, where 
about  1,26,000 new cases &71,000 deaths  attributable  to  cervical 
cancer are estimated to occur each year.
Cancer cervix constitutes 15-51% of all the female cancers and 
rate  of  age  standardized  incidence  range  from  17.2  to  55  per 
1,00,000 women in different regions of India.
More than 80% of cases are diagnosed at an advanced clinical 
stage and five year survival is less than 40%.
  In many developed countries a decline in the incidence of and 
mortality caused by cervical cancer has been observed in the past 30 
years as a result of screening cytology. Screening programmes do 
not exist in many developing countries, however and in some low 
resource settings, where cytology programme do exist they have not 
been effective in reducing the disease burden.
Due to difficulties in ensuring high quality cytology services 
in  many  settings,  there  have  been  significant  interest  in  new 
approaches of screening for precancerous lesions.
Of  these,  visual  inspection  of  cervix  is  a  promising option, 
especially for low resource settings.
Visual inspection with acetic acid, which identifies acetowhite 
lesions, has now been recognized as one of the promising methods 
for cancer detection from Indian & African studies as compared to 
cytology under similar circumstances.
Analysis  from  a  growing  number  of  studies  in  developing 
country settings indicate that the sensitivity of VIA is equivalent to 
or greater than Cytology, although its specificity is somewhat lower.
Other forms of visual inspection with Lugol’s Iodine (VILI) is 
similar to the Schiller’s Iodine Test used in the 1930s and has been 
reevaluated in recent studies as an alternative for use in low resource 
settings.
 The largest set of pooled data from IARC multicentre study of 
VILI indicates that it is more sensitive than or equally specific to 
VIA.
Many aspects of VIA &VILI make them appearing for use in 
low resource settings, as compared to Pap smear because of similar 
approaches  which  do  not  require  laboratory  involvement. 
Furthermore  non-Physicians  can  perform  the  procedure  with 
adequate  training.   Also visual  methods are  relatively simple  and 
inexpensive. The results are available immediately.  
AIM OF THE STUDY
The aim of the study is 
To calculate the accuracy of Papsmear, VIA, VILI in detecting 
precancerous  lesions  of  cervix,  reference  standard  being  biopsy 
cervix. 
To  calculate  the  sensitivity,  specificity,  positive  predictive 
value, negative predictive value of these three tests and to compare 
the results.
REVIEW OF LITERATURE
Historically  before  the  advent  of  papsmears  and  programmatic 
screening, health care workers relied on looking at the cervix to detect 
abnormalities. 
Schiller’s test has been used for many years to aid in differentiating 
mature normal epithelium from immature abnormal epithelium. 
After  1950s,  when  pap  smear  became  the  standard  for  cervical 
cancer screening many women were referred to colposcopy to confirm 
screening finding. 
Increasing number of women undergoing this test led to increased 
utilization of the colposcopy  (initially developed in 1930s) to confirm 
screening  findings.    Years  later,  given  the  expense  and  expertise  of 
colposcopy,  clinicians  began  to  explore  whether  unmagnified 
visualization of the cervix could be used as an adjunct to cytology so that 
patients in need of colposcopy could be identified more effectively and 
efficiently.
Also  papsmear  was  found  to  have  several  short  comings. 
Papsmear  quality  and  coverage  are  low.  In  addition,  even  in  middle 
income countries  programme  organization to  adequately  manage,  treat 
and  follow  up  women  with  identified  lesions  can  be  a  challenge 
(Sankaranayanan et  al  2001).  The  WHO Reproductive  Health  Library 
includes a summary of a meta analysis of pap test accuracy that reviewed 
62  studies  and  concluded  “the  paptest  may  be  unable  to  achieve 
concurrently high sensitivity and specificity” (Fahey 1995). To address 
these limitations, a number of new cervical cancer screening approaches 
are  being  evaluated,  including  visual  inspection,  automated  Pap 
screening,  alternative approaches to specimen collection, and protocols 
using HPV tests.
Four screening techniques based on visual inspection have been assessed 
for early detection of cervical neoplasia in low resource settings 
• Unaided visual inspection (also known as downstaging)
• Visual inspection with 3-5% acetic acid (VIA)
• Visual inspection with acetic acid  under magnification (VIAM)
• Visual inspection with lugol’s iodine (VILI) 
Unaided  visual  inspection  (also  known  as  downstaging)–  involves 
naked  eye  inspection  of  cervix  without  application  of  acetic  acids  to 
identify  abnormal  cervical  tissue  harboring  cervical  neoplasia  , 
particulary invasive cancer. Cross sectional studies in India have shown 
low sensitivity for visual inspection to detect cervical cancer precursors 
and it is no longer considered a suitable screening test (Sankarnarayanan 
et al, 1997, Basu et al, 2002).
VIAM  involves  the  use  of  low  level  magnification  (2-4x)  in 
visualizing the acetowhite lesions after application of acetic acid. The test 
characteristics of VIA & VIAM have been evaluated in cross-sectional 
studies  in  India  and  south  Africa.  (Denny  et  al,  2000  a,  2002), 
Sankaranarayan et al, 2004 e). The result from these studies indicate that 
magnification did not improve the test performance over and above that 
of naked eye visualization. Low level magnification is no longer widely 
used for visualization after application of acetic acid. 
VIA
Involves  naked  eye  inspection  of  the  cervix  one  minute  after 
application of 3-5% acetic acid. VIA has been widely investigated for its 
test characteristics in detecting, CIN 2-3 lesions and invasive cancer in 
several cross sectional studies, mostly in developing countries. (Londbe 
et al, 1997, Slarron et al, 1992, Denny et al, 2000a, Sankaranarayan et al 
1999).
Ottavino  et  al,  examined  2400  women  using  VIA  and  the 
colposcope ..VIA detailed abnormalities  in  98.4% of patients  assessed 
colposcopically  as  having  an  abnormal  transformation  zone  and  it 
correctly identified 98.9% of normal cases.
Van Le et al, found that VIA resulted in an additional 15% of CIN 
cases  being  identified  among  cytology  negative  women,  but  40%  of 
women with positive VIA underwent unnecessary colposcopy. 
Slawson et al, demonstrated that VIA might be helpful in reducing 
referrals for colposcopy.
Frisch et al, found that combining a negative cytology and negative 
VIA test resulted in a negative predictive value of 90%, greater than that 
obtained for  cytology alone,  but  with some loss of  positive predictive 
value. These studies demonstrated the potential value of VIA as a viable 
screening approach. But did not establish its test qualities as a primary 
screening method. 
The relative sensitivity of VIA to detect high grade precancerous 
lesions  and  invasive  cervical  cancer  varied  from  29%  to  95%  and 
specificity varied from 68% to 98% in cross sectional studies suffering 
from verification bias. (Slatson et al, Londhe et al, Sankaranarayan et al, 
1988, 1999, Crorje et al, 2001) 
In late 1990’s, Londhe et al, studied 372 women who underwent 
VIA, cytology and colposcopy in a gynaecology outpatient clinic. VIA 
identified 78% of HSIL and stage I cancer, diagnosed through colpscopy 
3.5 times more than those identified via cytology.   
Sankaranarayan et al, 1998 studied 3000 women attending cancer 
detecting  clinics,  conducted  as  a  part  of  the  community  outreach 
programs in Southern Kerala, by Regional Cancer Center, Trivandrum. 
They had VIA and cytology provided by trained cytotechnicians. Those 
positive  on  one  or  both  screening  tests  or  those  who  had  clinically 
suspicious lesions even if the tests were negative were investigated with 
colposcopy  and  directed  biopsy  if  necessary.  Those  with  moderate 
dysplasia or worse lesions diagnosed by histology were considered true 
positive. The detection rate of true positive cases were compared. VIA 
detected  (90.1%)of  true  cases  and  Cytology  (86.2%)  of  true  cases 
yielding sensitivity ratio of 1.05. As the detection rates were similar, the 
study suggested further evaluation of VIA in low resource settings. 
In the study by Megevand et al, in South Africa, VIA & cytology 
were performed in a mobile unit. About 2426 women were involved. In 
that  setting,  VIA detected 65% of high grade squamous intraepithelial 
lesion confirmed by reference standard.
In another study from South Africa. Denny et al, 1998 looked at 
the  comparative  performance  of  VIA,  cytology,  HPV  testing, 
Cervicography. About 2754, women were recruited. The study showed 
that  VIA and HPV were  similar  to  cytology  in  their  ability  to  detect 
HSIL. VIA however yielded more false positive. The sensitivity of VIA 
was  70%  and  specificity  was  79%.  The  study  also  showed  that 
magnification did not improve the sensitivity.
In  these  studies  the  reference  investigation  by  colpscopy  was 
carried out only in test positive women and a small  proportion of test 
negative  women  with  the  result  that  these  studies  suffered  from 
verification bias. 
University of Zimbabwe JHPIEGO 1998, cervical cancer project 
was the first  study to yield direct  estimate  of  sensitivity  & specificity 
because all women testing negative or positive on screening, were offered 
the reference standard  (colposcopy) thus avoiding verification bias. In 
that  study  about  10,934  women  were  screened  by  six  trained  nurse 
midwives at 15 primary care clinics at Zimbabwe. The sensitivity of VIA 
was 1.75 times higher than cytology (76.7%) versus 44.3% respectively), 
whereas the specificity was 1.4 times (64% versus 90.6%.) lower. The 
study  showed  that  VIA  is  highly  sensitive  and  could  be  valuable  in 
detection of precancerous lesion of the cervix, but emphasis to increase 
the specificity was made. 
Department  of  Obstetrics  &  Gynaecology,  MAMC,  New  Delhi 
conducted a study involving 400 women to assess the sensitivity of VIA 
and cytology for detection of precancerous and early cancerous lesions. 
The concluded that VIA was very sensitive for ectocervical lesions and 
its  immediate  results  help  to  see  and  treat  at  the  first  visit.  The  cost 
detection of one true lesion through acetic acid application (Rs.1699) was 
much lower as compared to the cost involved in cytology detected true 
lesion (Rs.2227.00). They concluded that acetic acid may be a suitable 
low cost and feasible alternative in resource poor setting. 
Basu, et al, studied, Visual inspection with acetic acid and cytology 
in early detection of cervical neoplasia, Kolkata, India. 5881 women aged 
30-65 years were screened by VIA/VIAM/cytology. Positive cases were 
subjected  to  biopsy  cervix.  18.7%,  17%,  8.2%  tested  positive  for 
VIA/VIAM/cytology  respectively.  VIA and  VIAM are  more  sensitive 
than cytology. 
Tayyeb R et al,  2003, conducted a study at Gangaram Hospital, 
Lahore from Jan.1996 - Dec. 1999. 501 women were screened with pap 
smear and VIA. Positive cases were subjected to colpscopy & directed 
biopsy if  necessary. Sensitivity of papsmear was 46.9% and of VIA was 
93.9%, Specificity was 30.4% & 69.5% respectively. Accuracy of VIA 
was 77.5% compared to 52.8% of that of papsmear. 
Five screening methods, VIA & VILI, Papsmear and HPV testing 
were evaluated in 11 IARC studies in Africa & India. (5 centres in India, 
Mumbai, Jaipur, Trivandrum, Dindigul and Kolkatta).
More than 58,000 women, aged, 25-64 years were tested with 2-5 
screening tests and outcome verification was done on all women. 
                                            Sensitivity       Specificity 
VIA 83% 85%
VILI 93% 86%
Papsmear 57% 93%
The  major  finding  from  the  study  was  the  consistently  higher 
sensitivity but equal specifity of VILI  as compared  with VIA. 
VIA is being evaluated in three randomized intervention trials in 
India, to assess the reduction in incidence of and mortality from cervical 
cancer as compared to control group with no screening. (Sankaranarayan 
et al, 2003 a, b, 2004 c,d)
Sankaranarayan et al,  assessed the effect of visual screening using 
VIA on cervical cancer incidence & mortality in a cluster randomized 
controlled trial in Dindugal, Tamilnadu. Women aged 30-50 years in 113 
clusters in Dindugal district were randomized to VIA screening by nurses 
(57 cluster, 49311 women) and a control group (30,958 women). 31,343 
were screened and 3088 had positive screen. Screen positive women were 
subjected to colposcopy / biopsy and those with CIN were treated. 20% 
of cancer detected at early stage were in the VIA group and 10% were in 
the control group. With an average of 4.95 and 5.20 years of follow up, in 
the VIA and control group, Cervical cancer incidence and mortality rates 
were lower in the VIA groups as compared to study group. A significant 
reduction of 25% in incidence and 35% in mortality has been observed in 
VIA group. 
An  innovative  option,  taking  advantage  of  the  immediate 
availability of test results with VIA is the Screen and Treat or Single visit 
approach.    The safety, acceptability and feasibility of such a single visit 
approach combining  VIA and cryotherapy was  assessed  in  a  study  in 
Thailand. Trained nurses tested 5999 women with VIA and 798 (13.3%) 
women were VIA positive.  Overall,  756 women received cryotherapy, 
and at a one year follow up visit, the VIA test negative  among treated 
women was 94.3%.
An IARC,  multicentric  cross-sectional  study,  comparing the test 
characteristics  of  visual  inspection  with  lugol’s  iodine  and  visual 
inspection  with  acetic  acid  was  conducted  involving  5,200  healthy 
women, aged 25-59 years in kerala, India. VILI was performed after VIA 
and colposcopy was the reference standard. The study established that 
VILI has a significantly higher sensitivity than VIA, to detect CIN 2-3 
lesion. (92.3% vs 73.8%). But the specificity of both tests were similar 
(84.0%) vs 82.4%).
To complement the growing body of evidence of the accuracy 
of VIA, a recent study examined the reliability of VIA.  The data 
showed  moderate  to  substantial  interrate  reliability  for  clinician 
assessment of cervical photographs taken after using the acetic acid 
wash.   This  reliability  statistics  is  comparable  to  similar  tests  of 
interrates agreement for colposcopy, cervical cytology and histology 
(Sellors et al, 2002) and is a significant step towards validating the 
accuracy of the test.
Researches have also been developing mathematical models to 
evaluate the cost benefit of alternative screening strategies such as 
VIA.   In  a  model  based  on  data  from Thailand,  VIA  saved  the 
greatest  number of  lives and was associated  with the  least  costs, 
when used to screen women between the age of 35-55 years at five 
years  intervals  and coupled  with  immediate  treatment  of  positive 
results. (Meadel blatt et al 2002).  Furthermore, in a study simulating 
conditions in South Africa, VIA followed by immediate cryotherapy 
is  associated  with  projected  26% reduction  in  incidence  and was 
found to be economical in comparison to no screening.
The  study  conducted  by  division  of  Cancer  Epidemiology  & 
Genetics  –  National  Cancer  Institute,  Maryland,  USA involving  1921 
asymptomatic women compared the efficacy of VIA and papsmear as a 
screening modality for detecting cancer cervix. They concluded that not 
only in low resource setting, but also in well equipped health center VIA 
is a good screening modality. 
Test performances of various modes of screening 
in different studies
AUTHOR Cytology VIA VIAM VILI
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De Vuvst et al 
2005 (7)
83.3 94.6 73.3 80.0 - - - -
Goel et al 2005 
(8)
50.0 97.0 96.7 36.7 - - - -
Ghaemmmagham
i et al (2004), (9)
72.0 90.2 74.3 94.0 - - - -
Sankara 
narayanan et al, 
2003 (15)
72.1 91.6 93.4 85.1 - - - -
Singh et al, (12) 73.3 99.0 86.7 94.3 - - - -
Lancet 1999 (13) 44.3 90.6 76.7 64.1 - - - -
Sankara 
narayanan et al, 
1998(14)
86.2 91.3 90.1 92.2 - - - -
Shastri et al 2005 
(6)
57.4 98.6 56.9 88.4 64.9 86.3 75.4 84.3
Basu et al 2003 
(10)
29.5 92.3 55.7 82.1 60.7 83.2 - -
Sankara 
narayanan et al, 
2003 (11)
81.9 87.8 82.6 86.5 - - 87.2 84.7
Parashari et al, 
2000 (20)
78.9 99.0 - - 82.9 94.3 - -
Sankara 
narayanan et al, 
2004 (18)
- - 76.8 85.5 - - 91.7 85.4
Sankara 
narayanan et al, 
2004 (19)
- - 60.3 86.8 64.2 86.8 - -
Denny et al, 2002 
(16)
- - 70.0 79.0 74.0 77. - -
Belinson et al, 
2001 (21)
- - 71.0 74.0 - -
Winkler et al 
2003 (17)
- - 60.0 69.0 - -
CIN
The  epidemiological  data  correlate  well  with  the  current 
understanding  of  the  pathogenesis  of  cervical  neoplasia.  The 
incidence of cervical dysplasia is reported to be 15:1000 in women 
who were cytologically screened. The incidence of severe dysplasia 
is reported to be 5:1000 according to ICMR studies. (SHAW)
The  period  of  early  squamous  metaplasia  is  the  time  of 
greatest risk for cellular transformation and development of  cervical 
neoplasia.In  this  period  young  metaplastic  cells  have  phagocytic 
properties and if some potent mutagen is present in the vagina during 
this time, epithelium might undergo the cellular transformation. The 
early squamous metaplasia occurs almost exclusively in puberty and 
early adolescence and in the first pregnancy. Therefore women who 
begin sexual  life  at  an early age when the  metaplastic  process is 
more active, have a greater chance of developing cervical carcinoma. 
      Age adjusted incidence rates for invasive cancer ranges from 19-
44/100000  women  in  various  cancer  registries  in  India.  Higher 
incidences noted in Chennai 43.5/100000 followed by 30.1/100000 
at Delhi and 19.4/100000 at Mumbai.
The cumulative risk of CA cervix is 1.58% in Mumbai and 
3.6% in Chennai. In other words, 1 in 62 women in Mumbai and 1 in 
28  women  in  Chennai  may  develop  cancer  cervix  in  their  life 
(ICMR-1992)
Natural history of CIN
Original squamous epithelium is derived from the congenital 
sinus  epithelium,  starts  at  the  vulvovaginal  line,  lines the  vagina, 
covers the major portion of the cervix and abuts upon the columnar 
epithelium to form the original squamocolumnar junction.
Under low vaginal acidity, the reserve cells proliferate, lifting 
the  columnar  epithelium.  There  is  centripetal  growth  of  original 
squamous epithelium growing beneath the columnar epithelial cells. 
Process of squamous metaplasia begins in the lips of the columnar 
villi which are first exposed to vaginal acidity.
A new squamocolumnar junction is continuously formed that 
gradually replaces the native columnar epithelium .The deeper clefts, 
however, may not be completely replaced by metaplastic epithelium, 
traped under the squamous epithelium resulting in the formation of 
nabothian  cysts.  Gland  openings  and  nabothian  cysts  mark  the 
original  squamocolumnar  junction  and  the  outer  edge  of  the 
transformation  zone.  The  area  between  original  squamocolumnar 
junction and the new original squamocolumnar junction is referred 
as Transformation Zone (TZ)
Physiological transition occurs during 3 phases of life.
1. Foetal
2. Menarche
3. First Pregnancy
Anatomy of Transformation Zone
Proximal border of Transformation Zone is the upper limit of 
squamous  metaplasia  where  the  immature  squamous  metaplasia 
abuts a circumferential ring of unaltered columnar epithelium.
Original squamocolumnar junction has 4 layers.
1. Basal layer: Single row of immature cells, with large nuclei and 
small cytoplasm.
2. Parabasl layer: Two to four rows of cells that have normal mitotic 
figures.
3. Intermediate layer: Includes four to six rows of cells with large 
amount of cytoplasm in a polyhedral shape separated by intercellular 
space.
4. Superficial layer: Includes five to eight rows of cells with small 
uniform  pyknotic  nuclei  and  acidophilic  cytoplasm  filled  with 
glycogen. These cells exfoliate and form the basis for Pap smear.
Columnar epithelium
Single layer of columnar cells with mucus at  the top and a 
round nucleus at the base.
Metaplastic epithelium :
Transformation  from  Columnar  epithelium  to  squamous 
epithelium is known as metaplasia to the histologists and as TZ to 
the colposcopists.This is the area of development of neoplasia and 
the  area  of  interest  to  the  colposcopists.  It’s  caudal  limit  is  the 
original  squamocolumnar  junction  and  cephalic  limit  is  the  new 
squamocolumnar junction.
Pathogenesis of CIN  
In most cases, CIN is believed to originate as a single focus in 
the transformation zone at the advancing SCJ. The anterior lip of 
cervix is twice as likely to develop CIN as the posterior lip and CIN 
rarely originates in the lateral wall.
Once CIN occurs, it can progress horizontally to involve the 
entire  TZ,  but  usually  does  not  replace  the  original  squamous 
epithelium. Proximally CIN involves the cervical clefts and the area 
tends to have more severe lesions.
CIN is most likely to begin either during menarche or after 
first  pregnancy,  when  metaplasia  is  more  active.  Conversely,  a 
women who has reached menopause without  developing CIN has 
little metaplasia and is at a lower risk.
Progression and regression of CIN
The spontaneous regression rate of biopsy proven CIN I is 60-
85% in prospective studies. This regression typically occurs within a 
2 year follow up with cytology and colposcopy.
This information has led to the recommendation that patients 
who have biopsy diagnosis of CIN I with satisfactory colposcopy 
and who agree to the evaluation every 6 months can be treated by 
observation. If the lesion progresses in follow up, persistent after 2 
years, ablation is recommended (Novak’s gynaecology)
Etiology and risk factors
1. Marriage and sexual behaviour
Increased risks are associated with the coitus at an early age, 
coitus with multiple sexual partners, and coitus with high risk men 
(Miller et al 1976, Canadian Task FORCE -1982)
2. Local hygiene
Cancer cervix is found to be positively associated with lack of 
daily genital washing and negatively with the use of clean sanitary 
napkins during menstruation (Zhang et al.1989)
3. Contraception
Barrier methods may be protective. But OCP increases the risk 
of  CIN  and  invasive  cancer  which  is  attributed  to  the  hormonal 
changes produced in the cervical epithelium.  ( Beral et al, 1988)
4. Dietary factors
Deficiency of Vit A, C, E and Folic acid are related to cancer 
cervix and dietary supplementation of these vitamins may prevent its 
occurrence (Verrult, 1989)
5. Smoking and douching 
Smoking and douching with tar substance may have a role in 
CIN (Winkelstein et al, 1991).Smoking more than 10 cigarettes per 
day had increased the relative risk to get CIN and invasive cancer 
(Nunez et al, 2002)
6. STD
There is  a  definitive association of Human Papilloma Virus 
(HPV)-16,18,31,33  with  CIN.   HPV-16  is  associated  with  CIN. 
HPV-16 is associated with high grade squamous cell carcinoma and 
HPV-18  is  associated  with  adenocarcinoma,  HPV  -31,33,35  are 
associated with intermediate oncogenicity (Crum et al,1985.Levine 
ET AL,1984).  Increased risk of cervical cancer has been reported 
with other  STD infections like HSV-2,  HIV,  CMV.  This  risk is 
found  to  increase  significantly  with  increase  in  the  number  of 
apparent organisms. (Schmauz et al.1989)
7. Immunosuppression
Both preinvasive and invasive lesions are more prevalent in 
chronically immunocompromised women, eg in HIV (Maimen et al-
1998) and in renal transplants (Alhoub et al-1988 and Mayemon et 
al-1981)
8. Parity
Although multiparity is associated with increased incidence of 
carcinoma  cervix,  there  is  no  significant  evidence  to  prove  it. 
(Cramer et al, 1986) 
The transformation to premalignant changes is a rapid process 
that  lasts  for  days  or  weeks  at  the  most,  but  promotion of  these 
changes is a long term process. Some lesions can stay on the cervix 
indefinitely without change and some can progress quickly to CIN or 
invasive carcinoma depending on host response.
Dietary factors 
Deficiency of 
Vitamin A and 
folic acid
HPV Types – 16, 18, 31, 33
HSV – 2
HIV, CMV
Altered immune status
• HIV
• Renal transplants
C I N
Multiple sex partners
OCP
Smoking
Poor personal hygiene 
Low socio economic 
status
Early age at first coitus
Scheme of pathogenesis of cervical neoplasia from STAFLA 
MATTINGLY RF. AMJ. O.G. 1977
Low pH of vagina
Columnar epithelium
Early metaplasia
Physiological metaplasia Atypical metaplasia
Normal Transformation zone Abnormal Transformation Zone
Well differentiated 
squamous epithelium
Adequate host 
response
Inadequate 
host response
No progression Dysplasia
CIN
Invasive Carcinoma
CIN II and CIN III require treatment. This is based on meta 
analysis showing that CIN II progresses to CIS in 20% of cases and 
to invasion in 5%
CIN Regress Persist PROGRESS 
TO CIN III
Progress to 
Invasive CA
CIN I 57% 32% 11% 1%
CIN II 43% 35% 22% 5%
CIN III 32% 56% > 12%
From Ostor AG-Inter.J.Gynaecol, Pathology, 1993; 12)
Precursors of invasive squamous cell carcinoma
The term dysplasia was first introduced by Reagon in 1953. 
Dysplasia represents a change causing an alteration and disorderly 
arrangement of the differentiated basal cells of stratified squamous 
epithelium.
The  three  degrees  of  dysplasia  mild,  moderate,  severe 
according to Novak and Woodruff (1979) are characterized by,
I) Mild
The dysplastic cells extend from one quarter to one third of the 
way from the basal layer.
II) Moderate 
Cellular aberrations extend through one half to two third of the 
thickness of epithelial layer.
III) Severe
The  dysplasia  cells  penetrate  through  75-90%  of  the 
epithelium.
Histopathology  appearance  of  severe  dysplasia  resembles 
carcinoma in situ with the exception that a few cell layers near the 
surface are still capable of maturation.
   Carcinoma  in  situ  is  characterized  by  malignant  changes 
involving  the  whole  thickness  of  squamous  epithelium  from  the 
basement  membrane  to  the  surface,  disclosing  an  immature 
disorganized pattern with complete loss of parity.
Richart (1966) first introduced the term cervical intra epithelial 
neoplasia  (CIN)  to  denote  the  ranging  degrees  of  intra  epithelial 
abnormalities.  The  varying  degree  of  CIN  ranging  from  mild 
dysplasia  to  carcinoma  in  situ  represents  a  continuum  in  the 
neoplastic process. 
Richart (1966) graded the various degrees of CIN into
CIN I-Mild dysplasia
CIN II-Moderate dysplasia
CIN III-Severe dysplasia and carcinoma in situ
Carcinoma  in  situ  has  been  grouped  under  CIN,  although 
histologically there is a slight difference between severe dysplasia 
and carcinoma in situ.
Therapeutically  and  prognostically  there  is  hardly  any 
difference between the two.
Feature variations with increasing severity of dysplasia
Decrease Increase Varies
Cellular cohesion
Amount of cytoplasm
Multinucleation
Degree of maturation
Normal flora
Mitosis
Nuclear cytoplasmic ratio
Annisochromatism
Nuclear  membrane 
irregularities 
Nuclear hypertrophy
Anisokaryosis
Hyperchromatism
Nucleoli
Screening procedures for CIN
1. Pap smear
2. Colposcopy
3. Cervicography
4. Speculoscopy (VIA, VILI)
5. HPV DNA detection and typing
6. Polarprobe (Truscan)
7. Spectroscopy
Pap smear
The Pap smear initially described by Papaniculaou and Traut 
is  used  to  detect  exfoliative  cells  from  the  cervix  that  may  be 
precancerous or cancerous
Conventional Pap smear
According to American cancer society, ideal time to take Pap 
smear is 5 days after menstruation. The patient should be instructed 
not to use vaginal douche or any type of lubricant or spermicide for 
24  hours  prior  to  having  a  cytologic  specimen  obtained.  The 
ectocervix and the area of vagina adjacent to the cervix must be fully 
visible when the smear is obtained. The patient should not bleed and 
should  not  have  marked vaginal  infection.  The  infection must  be 
treated accordingly and patient must be rescheduled for Pap smear 
during next cycle.
The  smear  is  taken  with  Ayer’s  spatula  or  with  moistened 
brush around the external os by making 360º rotation with minimal 
pressure and smeared and fixed in a glass slide with 95% alcohol. 
Staining done with papanicolaou staining procedure which employ, 
• Hemotoxylin as a nuclear stain and 
• Orange  G-6  Eosin  alcohol  (Eo-36)  as  cytoplasmic 
counterstains.the  slides  are  finally  mounted  in  Canada 
balsam and examined and interpreted.
Various forms of interpretations
Papanicolaou Richart WHO(1975) BETHESDA 
(1998)
Gr I-normal cells normal Negative  for 
cancer
normal
Gr-II-slightly abnormal, suggestive 
of  inflammatory  changes.  repeat 
smear after treating infection
negative Atypical 
squamous cells
Inflammatory
HPV
ASCUS
Gr-III-More,serious  type  usually 
indicative of biopsy
CIN I Mild dysplasia Low SIL
Gr-IV-Distinctly  abnormal  and 
definitely require biopsy
CIN II
CIN III
Moderate  and 
severs 
dysplasia
High SIL
Gr V- SCC SCC SCC SCC
Cervical biopsy
Gold  standard  confirmatory  test.  Different  types  of  biopsy 
methods are done which include punch biopsy, loop excision biopsy 
and  conisation  biopsy.   Punch  biopsy  is  the  most  commonly 
practiced method but it tends to crush and may not include stroma.A 
low  voltage  diathermy  loop  biopsy  requires  more  sophisticated 
equipment  but  can  control  hemorrhage  and  produce  samples  of 
greater  size.  Prendiville  et  al,  have  shown  that  the  artefactual 
damage is minimal and a larger biopsy can be taken for the diagnosis 
of micro invasion or invasion.
Screening intervals
ACS-American cancer society 2002 guidelines
1.  Age to  initiate  screening:  three  years after  the  onset  of  sexual 
activity, not later than the age 21. 
2.  Screening  frequency:  annually  with  conventional  cytology  or 
every  2  years  with  liquid  based  cytology.  After  the  age  of  30, 
women with 3 consecutive normal tests may be screened every 2-3 
years
3.  Screening  after  hysterectomy:  no  cytologic  testing  after  total 
hysterectomy for benign conditions
4. Discontinuation: After the age 70
5. Routine screening for HPV infection: not yet FDA approved. It 
approved, conventional or liquid based cytology combined with test 
for DNA from high risk HPV types should be performed not more 
than every 3 years.
Indication for colposcopy :
 Suspicious looking cervix
 Invasive carcinoma,  CIN 2, CIN 3  on cytology
 Persisting CIN 1 abnormalities on cytology
 Infection with HPV
 VIA / VILI positive patients.
REID’S COLPOSCOPIC INDEX
Feature 0 points 1 point 2 points
Colour of 
acetowhite 
(AW) area
Low-intensity aceto whitening 
snow-white, shiny AW ; indistinct 
AW ; transparent AW ; AW 
beyond the transformation zone
Grey white AV with 
shiny surface
Dull, oyster-white ; 
Grey
AW lesion 
margin and 
surface 
configure 
tion
Feathered margins ; angular, 
jagged lesions ; flat lesion with 
indistinct margins ; 
microcondylomatous or 
micropapillary surface
Regular lesions with 
smooth, straight 
outlines
Rolled, peeling 
edges ; internal 
demarcations (a 
central area of high 
grade change and 
peripheral area of 
low grade change)
Vessels Fine / uniform vessels ; poorly 
performed patters of fine 
punctuations and / or fine mosaic ; 
vessels beyond the margin of 
transformation zone; fine vessels 
within microcondylomatous or 
micropapillary lesions
Absent vessels Well defined coarse 
punctuation or 
coarse mosaic
Iodine 
staining
Positive iodine uptake giving 
mahogany brown colour ; negative 
update of lesions scoring 3 points 
or less on above three categories
Partial iodine uptake 
by a lesion scoring 4 
or more points on 
above three 
categories variegated, 
speckled appearance
Negative iodine 
uptake by a lesion 
scoring 4 or more 
points on the above 
three criteria
Scoring : A score of 0 to 2 points – Likely to be CIN 1  ;  3-4 points – overlapping lesion : 
likely to be CIN 1 -2 ; 5 to 8 points – likely to be CIN 2-3 lesions.
Pathological basis of VIA
Application  of  5%  acetic  acid  dissolves  mucus,  Induces  intra 
cellular dehydration, cause a reversible coagulation (or) precipitation 
of  cellular  protein.  Thus the  effect  of  acetic  acid depends on the 
amount of cellular protein present in the epithelium.
Areas of increased nuclear activity and DNA content exhibit the 
most dramatic white color change.
When acetic acid is applied to normal squamous epithelium, little 
coagulation occurs in the superficial  cell  layer, as this is sparsely 
nucleated.
Although  the  deeper  layer  contains  more  nuclear  protein,  the 
acetic  acid may not  penetrate  sufficiently and hence the resulting 
precipitation  is  not  sufficient  to  obliterate  color  of  underlying 
stroma.  Areas  of  the  CIN and  invasive  cancer  undergo  maximal 
coagulation due to their higher content of nuclear protein.
The acetowhite appearance is not unique to CIN and early cancer. 
It  is  also  seen  in  other  conditions  like  immature  squamous 
metaplasia,  in  healing  &  regenerating  epithelium,  Leukoplakia, 
Condylomata when increased nuclear proteins are present. 
BASIS OF VILI
1) Squamocolumnar  epithelium  contains  glycogen  whereas 
precancerous  lesions  & invasive  cancer  contain  little  or  no 
glycogen
2)  Iodine  is  glycophilic  and  is  taken  up  by  the  squamous 
epithelium, staining it mahogany brown or black.
3)  Columnar  epithelium  does  not  change  color  as  it  has  no 
glycogen
4) Immature metaplasia,  a red inflammatory lesion are at  most 
only partially glycogenated &upon stained appear as scattered, ill 
defined uptake areas.
IARC criteria for interpretation of VIA and VILI
VIA Positive:
• Well  defined, sharp,  distinct,  dense  acetowhite  area  with or 
without raised margins, abutting the squamocolumnar junction 
in the transformation zone.
• Strikingly dense acetowhite area in the columnar epithelium
• Condyloma  &  leukoplakia  occurring  closer  to  the  squamo 
columnar junction turning     white after application of acetic 
acid.
VIA Negative:
• No acetowhite lesion on the cervix
• Polyps protruding from the cervix with blush-white acetowhite 
areas.
• Nabothian cyst appearing as button-like areas, whitish areas or 
pimples.
• Faint  line  like  or  ill-defined  acetowhitening   at 
squmocolumnar junction
• Shiny,  digitative,  inkish-white,  cloudy  white,  bluish  white, 
faint  patchy,  or  doubtful  lesion  with  ill  defined  indefinite 
margin blending with the rest of cervix
• Angular,  irregular,  digitations,  acetowhite  lesion  resembling 
geographical region far away from the transformation zone.
• Ill  defined,  patchy,  pale  acetowhite  areas  in  the  inflamed 
unhealthy,  ulcerated  cervix  with  bleeding&  mucopurulent 
discharge.
• Streak like acetowhitening in the columnar epithelium.
• Dot like areas in the endocervix, which are due to grape like 
columnar epithelium staining with acetic acid.
VILI POSITIVE:
Dense, thick, bright mustard yellow or saffron yellow iodine 
non-uptake  areas  abutting  the  squamocolumnar  junction  in  the 
transformation zone.  Precancerous lesions & invasive cancer do not 
take up iodine, as they lack glycogen and appear as well  defined 
thick, mustard or saffron yellow areas.
VILI NEGATIVE:
• Normal  cervix  where  squamocolumnar  epithelium  turns 
mahogany brown or black and the columnar epithelium does 
not change color. no yellow areas seen.
• In ectropion, where an extensive areas of columnar epithelium 
with regular margin on the ectocervix remains without color 
change.
• Patchy,  indistinct,  ill  defined,  colorless  or  partially  brown 
areas are seen in the cervix.
• None  or  partial  Iodine  uptake,  pale  areas  corresponding 
nabothian follicles and (or) polyps are seen.
• Stippling  (or)  leopard  skin  appearance  associated  with 
T.VAGINALIS infection.
Pepper  like  non-iodine  uptake  areas  seen  in  the  squamous 
epithelium far away from squamocolumnar junction.
When  satellite,  thin  yellow,  non-iodineuptake  areas  with 
angular  (or)  digitating  margin  resembling  geographical  areas  are 
seen far away from squamocolumnar junction.
Test Strengths Limitations status
Conven 
tional 
cytolog
y
• History of long use
• Widely accepted
• Permanent record of 
test
• Training  and 
mechanism  for 
quality  control 
established
• Modest  investments 
in  existing 
programmes  can 
improve services
• High specificity
• Results not immediately 
available
• Systems  needed  to 
ensure  timely 
communication  of  test 
results and follow up of 
women
• Transport  required  for 
specimen  to  laboratory 
and for results to clinic 
• Requires  laboratory 
quality assurance
• Moderate sensitivity
• Available  in 
many  countries 
since the 1950s
• Cytology  based 
programmes have 
reduced  cancer 
mortality  in 
developed 
countries
Visual 
methods 
(VIA 
and 
VILI)
• Relatively  simple 
and inexpensive
• Results  available 
immediately
• Can  be  performed 
by  wide  range  of 
personnel after short 
training
• Low  level  of  infra 
structure required
• Can  be  combined 
with  offer  of 
immediate treatment 
in  single  visit 
approach
• High  provider 
variability
• Lower  specificity 
resulting in high referral 
rate and over treatment
• No permanent record of 
test
• Not appropriate for post 
menopausal women
• Lack of standardization
• Frequent  retraining 
needed
• Limited  evidence 
available
• Recommended 
for  screening  in 
low  resource 
settings 
• Large 
randomized 
controlled  trails 
under  way  to 
determine  effect 
on  cancer 
incidence  and 
mortality

MATERIALS & METHODS
This cross sectional study was carried out in the gynecology OPD 
from September 2007 to October 2008.
A total of 250 women without history of active STD, Cervical 
neoplasia in the age group of 20-45 years were examined.
Women were considered eligible if they met all of the following 
requirement
1. Were aged between 20-45 years
2. No previous surgical procedure on the cervix or corpus
3. Had no history of abnormal Pap test in the past year.  
4.  Did  not  have  any  confirmed  (or)  clinically  suspected 
immunosuppression
Cases referred from PHCs as a part of screening programme 
were also eligible. 
Exclusion criteria:
• Were aged  < 20 yrs
• Unmarried
• H/O Hysterectomy
• Previous surgical procedures on cervix
• Gross tumor on cervix
• Pregnancy
An oral questionnaire was administered to all women pertaining 
to  age,  parity,  education,  socioeconomic  status,  contraception 
history, chief gynaecologic complaints.
They  were  examined  using  an  unlubricated–bivalve  cusco 
speculam.
The cervix was exposed properly and excessive discharge when 
present was gently wiped away using a saline soaked cotton swab.
Cervix was closely inspected for macroscopic abnormalities such 
as erosion, polyp, congestion, nabothian cyst, ulceration, growth.
First Pap smear was taken using Ayer’s spatula. 
Then visual inspection with 5% acetic acid was done, 1 minute 
after application. Categorization was made as VIA Positive/Negative 
based on the criteria laid down by IARC.
After VIA, Lugol’s Iodine was applied to the cervix with help of 
cotton  swab  suck  and  naked  eye  examination  was  done. 
Categorization  was done  as  Positive  or  Negative  based on IARC 
Criteria (Positive Pap Smear)
VIA&VILI  Positive  women  were  subjected  to  colposcopically 
directed  cervical  biopsy  in  the  same  sitting.  But  for  Pap  smear 
positive cases.  Colposcopically directed biopsy was done in the next 
visit after seeing the results.
Careful examination of cervix and the transformation zone was 
carried out approximately  1 minute after applying 5% acetic acid in 
the entire cervix.
Acetowhite  epithelium,  Punctuation,  Mosaic  pattern,  Iodine 
negativity  &  atypical  vessels  prompted  colposcopicaly  targeted 
punch biopsies.
Cervical biopsies were fixed in formalin. Embedded in paraffin 
and processed into 5µm-thick haemotoxylin/eosin-stained section for 
light microscopy-following the routine diagnosis. 
Thus, positive pap smear VIA&VILI patients were subjected to 
Colposcopically  directed  Biopsy  & forwarded  for  Histopathology 
which was reviewed by Pathologists from Department of Pathology, 
Madurai Medical College as was the Pap smear for cytology. The 
reports were available within two weeks of the Pap smear or biopsy 
being taken. 
Statistical analysis:
• Cervical  biopsy  report  was  considered  as  the  gold 
stanadard
• Mild dysplasia was considered as positive-
• Sensitivity, specificity, positive and negative predictive 
values-were  calculated for  all  screening tests-by using 
the cervical biopsy reports as the gold standard.
RESULTS
Table – 1  -  AGE DISTRIBUTION :
Age in 
years
Screened Positive
Frequency 
(n=250)
Percentage Positive Percentage
20 – 24 36 14.4 - -
25 – 29 37 14.8 1 14.4
30 – 34 77 30.8 - -
35 – 39 64 25.6 3 42.8
40 – 45 36 14.4 3 42.8
Total 250 100% 7 100 %
Mean    - 32.44  yrs Mean   -  38.21 yrs
Among the 250 women screened
14.4% were between  20 – 24 yrs
14.8 % were between 25 – 29 yrs
30.8 % were between 30 – 34 yrs
14.4% were between  40 – 45 yrs
25.6% were between 35 – 39 yrs
Among those screened positive (out of 7 cases)  6 were  in the 
age group of 35-45 yrs.  Mean age of the women screened was 32.44 
yrs and Mean age of those screened positive was 38.21 yrs.
Table – 2  -  EDUCATIONAL STATUS :
Education No.of cases (n=250) Percentage
Illiterate 103 41.2%
Upto 10th standard 123 49.2%
+1/+2/Degree 24 9.6%
Among the 250 women studied, 46.2% (103/250) were 
illiterate, 49.2% (123/250) had high school education and 9.6% 
(24/250)  had higher education.
Table – 3  -  SOCIO-ECONOMIC STATUS :
Income per month No.of cases (n=250) Percentage 
I    <  1000 142 56.8 %
II   1000 – 1500 46 18.4 %
III  1500 – 2000 52 20.8 %
IV    >  2000 10 4 %
Majority, 56.8% of women belonged to low income group 
( < Rs. 1000 per month)
TABLE – 4  :  AGE AT MARRIAGE
Age at 
marriage
No.of cases 
(n=250)
Percentage Dysplasia 
(n=7)
%
<  15 yrs 33 13.2 - -
15-20 yrs 121 48.4 5 71.43%
20-25 yrs 73 29.2 2 28.57%
25-30 yrs 13 5.2 - -
> 30 yrs 10 4.0 - -
Total 250 100% 7 100%
Mean age at marriage - 19.42 years
48.4% (121/250) of those screened were married between the 
age of 15 – 20 years. The mean age at first  intercourse was 19.42 
years.
71.43% (5/7) of those diagnosed with CIN were married 
between the age of 15-20 yrs.  
28.57% (2/7) of those diagnosed with CIN were married 
between the age of 20-25 yrs.
Table -  5   :   Duration of Marital life :
Duration 
years
Cases Dysplasia
Frequency 
(n=250)
Percentage Percentage
<  5 yrs 45 18 - -
5 – 10 yrs 73 29.2 1 14.28
11 – 20 yrs 83 33.20 4 57.14
> 20 yrs 49 19.6 2 28.56
In the study group,  18% had  < 5 yrs of marital life.
29.2% had  5-10 yrs of marital life
33.2 % had 11-20 yrs of marital life and
19.6% had marital life of   > 20 yrs.
Table – 6     :    Multiple Sex Partner
> 1 partner No.of cases (n=250) Percentage
Yes 4 1.6 %
No 246 98.4 %
In the age group  -  1.6% had contact with more than 1 partner, 
Most of the patients gave no history of treatment for  STDs.
None of the screen positive patients gave h/o of contact with 
more than one partner
Table -  7   :   PARITY
Parity Cases CIN
Frequency 
(n=250)
Percentage Frequency Percentage
1 29 11.6 - -
2 106 42.4 2 28.57
3 97 38.8 4 57.14
4 18 7.2 1 14.28
Total 250 100 7 100 %
Among the 250 women studied
11.6% were primipara,  42% were para2,   38.8% were para 3 
and 7.2% were para 4 and above.
In the screen positive group, majority (5/7),  71% of them 
were para 3  and above.
Table -  8    :  CONTRACEPTION
Contraceptio
n
Cases Dysplasia
Frequency 
(n=250)
Percentage Frequency 
(n=7)
Percentage
Barrier 21 8.4 - -
OCP 3 1.2 - -
IUCD 18 7.2 1 14.28
Permanent 
sterlization
160 64.2 4 57.14
No 
contraceptive
48 19.2 2 28.57
Among  those  250  women  studied,   8.4%  practiced  barrier 
method, 1.2% were taking oral contraceptive pills, 7.2% had IUCD 
inserted, 64% of them were permanently sterilized, 19.2% did not 
adopt any form of contraception.  1 case (1/7) of mild dysplasia had 
Cu-T inserted 4 ½ years back. 4 of the positive cases (4/7)  were 
permanently sterilized.  2 of the positive cases (2/7) did not practice 
any form of contraception.
Table – 9  : Complaints
Complaints No.of cases 
(n=250)
Percentage Dysplasia 
(n=7)
%
White discharge 174 69.6 4 57.14
Lower abdominal pain 32 5.6 - -
Low back ache 18 4.8 1 14.28
Post coital bleeding 14 12.8 2 28.56
Intermenstrual bleeding 12 7.2 - -
In  the  study  group,  predominant  or  chief  complaints  were 
white discharge and lower abdominal pain. 69.6% of the cases had 
white  discharge.  20% had  abdominal pain and low back ache. Only 
5.6%  of  the  patients  had  post  coital  bleeding.   Intermenstural 
bleeding was seen in 7.2% of the cases.
Of those diagnosed with dysplasia,  white discharge was the 
predominant  complaint.  57.14%  (4/7)  of  those  diagnosed  with 
dysplasia gave history of white discharge.  28.56% (2/7) had post 
coital  bleeding as  the  predominant  complaint.  14.28% (1/7)  gave 
history of low backache.
Table – 10   :   Clinical appearance of Cervix :
Appearance of 
Cervix
No.of cases 
(n=250)
Percentage Dysplasia 
(n=7)
%
Normal 54 21.6 - -
Ectopy cervix 132 52.8 5 71.43
Hypertrophy and 
congestion
17 6.8 2 28.57
Nabothiancyst 43 18.0 - -
Cervical polyp 2 0.8 - -
When the cervix was visualized with cuscos speculum, cervix 
was healthy in 21.6 % of the patients and unhealthy in rest of the 
patients.
Ectopy cervix was seen in 52.8% of cases 17.0% of the 
patients had nabothian cyst.
Hypertrophy with congestion was present in 6.8% of cases. 
Cervical polyp was seen in 0.8% of the study subjects.
In 2 cases with severe dysplasia, cervix was hypertrophied, 
congested and badly eroded.
Table – 11   :   Papsmear Results :
Appearance of Cervix No.of cases (n=250) Percentage
Normal 64 25.6
Inflammatory 178 71.2
Mild dysplasia 5 2.1
Moderate dysplasia 1 0.4
Severe dysplasia 2 0.8
Total 250 100
25.6% (64/250) of the patient had normal papsmear.  71.2% 
(178/250) of the study group had inflammatory smear.
2.1% (5/250) of the patients had mild dysplasia. 
0.4% (1/250)  of the patients had moderate dysplasia.
0.8% (2/250) of the patients had severe dysplasia
Table – 12   :   Result of VIA:
VIA No.of cases (n=250) Percentage
VIA positive 75 30%
VIA Negative 175 70%
VIA was positive in about 30% of the study group and it was 
negative in 70% of the study subjects.
Table – 13   :   Result of VILI :
VILI No.of cases (n=250) Percentage
Positive 63 25.2%
Negative 187 74.8%
VILI was positive in 25.2% of the patients and it was negative 
in about 74.8% of the patients.
Table – 14  :   Biopsy Report
Biopsy Report No.of cases Percentage
Chronic cervicitis 65 76.4 %
Reactive squamous 
metaplasia
9 10.5 %
Hyperplasia of 
squamous epithelium
4 4.7%
Mild dysplasia 3 3.6%
Moderate dysplasia 1 1.2%
Severe dysplasia 3 3.6%
85 100 %
Of  the  study  population,  76.4%  were  diagnosed  to  have 
chronic  cervicitis.  Reactive  squamous  metaplasia  was  present  in 
10.5%  of  the  patients.  Hyperplasia  of  squamous  epithelium  was 
present  in  4.7%  of  the  patients.  3.6%  of  the  patients  had  mild 
dysplasia. Moderate and severe dysplasia was present in about 1.2% 
and 3.6% of the patients respectively.
Table – 15  :  Correlation of Papsmear with biopsy cervix
Papsmear Chronic 
cervitis
Meta 
plasia
Hyper 
plasia
Mild 
dysplasia
Moderate 
dysplasia
Severe 
dysplasia
Normal 10 3 2
Inflammatory 52 6 2 2
Mild 3 1 1
Moderate 1
Severe 2
65 9 4 3 1 3
2 cases reported as inflammatory smear by cytology had mild 
dysplasia in cervix biopsy
3 cases reported as mild dysplasia had chronic cervicitis
1 patient reported as mild dysplasia had severe dysplasia
1 patient reported as moderate dysplasia had same findings in 
biopsy cervix
2 patients reported as severe dysplasia were also found to have 
severe dysplasia in HPE report.
Correlation between papsmear and biopsy report for lesions 
diagnosed as moderate and severe dysplasia was  good.
Table : 16  Result of Screening Test compared with Final 
Disease status established by reference standard
Normal Mild 
dysplasia
Moderate 
dysplasia
Severe 
dysplasia
Total
VIA
Positive
Negative
69
174
2
1
1
0
3
0
75
175
VILI
Positive
Negative
56
187
3
0
1
0
3
0
63
187
Cytology
Negative
Positive
240
3
2
1
0
1
0
3
242
8
Table – 17  Calculation of Sensitivity, Specificity, PPV, NPV 
VIA VILI Papsmear
True Positive 6 7 5
False Positive 69 56 3
True Negative 174 187 240
False negative 1 - 2
Sensitivity -
TP x 100
TP& FN
85.7 % 100% 71.4%
Specificity -
TN x 100
TN& FP
71.6% 76.9 % 98.7 %
PPV –
 TP x 100
8.2% 11.11% 62.5%
TP & FP
NPV 
TN x 100
TN + FN
99.37% 100% 99.1%
The sensitivity, specificity, PPV, NPV of VIA are 85.6%, 
71.6%, 8%, 99.37% respectively.
The sensitivity, specificity, PPV, NPV of VILI are 100%, 
76.9%, 11.11%, 100% respectively.
The sensitivity, specificity, PPV & NPV of papsmear are 
71.4%, 98.7%, 62.5%, 99.1% respectively.
Correlation between Papsmear and Visual Findings
Table - 18
Papsmear VIA 
Positive
VIA 
Negative
Normal (242) 68 174
Abnormal (8) 7 1
Papsmear VILI 
Positive
VILI 
Negative
Normal (242) 55 187
Abnormal (8) 8 -
Of the 250 cases screened, papsmear is abnormal in 8 patients.
Correlation between abnormal papsmear and visual findings 
was studied.
VIA was positive in 7 of the 8 abnormal papsmear cases
1 patient with papsmear abnormality was negative with VIA.
VILI was positive in all the 8 abnormal papsmear cases.
DISCUSSION
Cervical  Cancer  is  the  second  most  frequent  cancer  world 
wide in women after breast  cancer.   However,  invasive cancer of 
cervix is considered to be preventable condition as it is associated 
with a preventive stage amenable to screening and treatment.
Mean age of the women screened was 32.44 years and mean 
age of those screened positive was 38.21 years. Dysplasia was found 
to be  more common between 35-45 yrs.  6 of the 7 patients  with 
dysplasia  were  in  the  age  group  of  35-45  years.  Kustagi  and 
Fernandes  in  their  study showed the  prevalence of  dysplasia  was 
higher in women over 30 years.  Vaidya showed in his study that 
CIN was more prevalent in the age group > 35 years.
Regarding educational  status,  abnormal  cervical  lesions  like 
chronic cervicitis, dysplasia and malignancies were common among 
illiterates. The same was confirmed in our study.
Socioeconomic  status  had  always  been  playing  an 
epidemiological role in genesis of dysplasia.  In our study, chronic 
cervicitis and dysplasia were common in low income group.  Poor 
personal  hygiene,  poor  living  conditions  and  early  age  at  first 
intercourse  are  factors  associated  with  both  low  socio  economic 
status and cervical cancer.
Regarding  parity,  our  study  showed  increased  incidence  of 
dysplasia  among  multiparous  women.   71%  of  those  screened 
positive  were  para  3  and  above.   The  other  two  cases  screened 
positive were para 2 one had mild dysplasia and the other subject 
had  severe  dysplasia.   Kusthagi  and  Fernandez  showed  the 
prevalence  of  CIN  was  significantly  higher  in  parity  of  >  2.  
This might be attributed to hormonal and nutritional charges 
that occur in pregnancy, immunosuppression during pregnancy and 
cervical trauma during vaginal delivery. (Becker et al)
Incidence of dysplasia (85.6%) was found to be common in 
those married for more than 10 year (about 85.67%). Kushtagi et al, 
had  demonstrated  the  severity  of  underlying  CIN  increased  with 
increase in the duration of marital life. 
1 patient with Cu-T had mild dysplastic changes in cytology 
and was proved with biopsy cervix. 57.14% of the cases screened 
positive for dysplasia were permanently sterilized.
Among  the  complaints,  white  discharge  was  present  in 
majority of women with chronic cervicitis, dysplasia and metaplasia. 
Excessive  vaginal  discharge  playing a  role  in  contributing  to  the 
development of CIN was also proved to be a risk factor in the study 
conducted  by  Vaidya  et  al.  In  their  study,  24%  had  vaginal 
discharge. 
On examination,  majority  of  the  patients  had ectopy cervix 
(52.8%).  In  all  patients  with  severe  dysplasia  cervix  was  badly 
eroded and was bleeding on touch.
Analysis of  results : 
The screen positivity rate for cytology was 3.3% and for VIA, 
VILI, it was 30%, 25.4% respectively.
High screen positivity rate for visual lesions could be 
attributed to large number of referral cases from other primary health 
centres as a part of screening programme. (Varumun kappom)
The sensitive of VIA, VILI and papsmear were 85.6 %, 100%, 
71.4% respectively.
Thus VILI was found to have the highest sensitivity and 
detected all the true positive lesions.
The specificities of VIA, VILI and papsmear were 71.6%, 
76.9% and 98.7%.
Thus papsmear was the most  specific test.   However,  lower 
specificity of the visual test,  means that larger number of women 
will need investigations and treatment.
The positive predictive value of VIA, VILI and papsmear were 
8%, 11.11% and 62.5% respectively.  
Papsmear  was found to have the highest  positive predictive 
value among the tests,  meaning that papsmear correctly identified 
abnormal lesions.
The negative predictive value of all the tests exceeded 99%.
64  (25.6%)  patients  had  normal  papsmear.  178  patients 
(71.2%) of the study group had inflammatory smear.  2.1% of the 
patients had mild dysplasia, 1.2% of the patients had moderate and 
severe dysplasia.  
Those with inflammatory smear were treated with antibiotics 
and subsequently followed up with repeat papsmear at a interval of 6 
months.
2 patients reported as inflammatory smear by cytology were 
positive with VIA and VILI and subsequently taken biopsy cervix 
showed mild dysplasia.
5 (2.1%) patients had mild dysplasia by cytology. Among the 
5 patients, 3 patients were found to have chronic cervicitis by biopsy 
cervix.  1 patient was confirmed to have mild dysplasia, 1 patient 
was found to have severe dysplasia. Correlation between papsmear 
and  biopsy  report  for  lesions  diagnosed  as  moderate  and  severe 
dysplasia was good.
The cytology findings in this study are similar to the finding 
reported by J.J. et al (1997). Normal or inflammatory in 97%, 1.6% 
showed LSIL, 1% showed HSIL.
It would be inappropriate to compare our small findings with 
the studies, involving large population in series of trials, still this has 
been necessary as part of study.  The sensitivity and specificity for 
cytology in the present study was 71.4% and 98.3% as compared to 
Sankaranarayan et al, 1998 with reported sensitivity of 86.2% and 
specificity of 91.3%.
In the recent review of the accuracy of cervical cytology based 
on  published  studies  from  developed  countries,  the  average 
sensitivity  for  cytology  ranged from 47% to  62% and specificity 
ranged from 60% to 95%.
The  sensitivity  and  specificity  of  cytology,  73.4%,  98.7% 
respectively in this study were comparable to that of
 Singh et al 2001 - Sensitivity – 73.3%
- Specificity – 99.0 %
Parashri et al 2000 - Sensitivity -  78.9%
- Specificity -  99.0 %
Addition of visual test with papsmear in parallel was found to 
increase  the  sensitivity  of  papsmear  with  a  compromise  in 
specificity.
Among  the  single  test  in  our  study,  cervical  cytology 
demonstrated  the  best  balance  of  sensitivity,  specificity  and 
predictive value.
Results of VIA / VILI
30% of those screened were positive for VIA.  25.2% were 
positive for VILI.
The sensitivity, specificity, PPV and NPV for VIA are 85.6%, 
71.6%, 8 %,  99.3% respectively and for VILI 100%, 76.9%, 11.1% 
and 100% respectively.
The sensitivity and specificity are comparable to Cecinni et al, 
with  a  sensitivity  and  specificity  of  88%  and  75%  respectively. 
Thus VIA & VILI were more sensitive than papsmear for detection 
of preinvasive and invasive stage of cervical carcinoma as in other 
study by Denny et al.  However, study by Sankaranarayanan et al, 
reported equally comparable specificities for both tests, 93.2% for 
VIA and 92.7% for cytology which is not similar to our study.  High 
number of false positive and consequently low specificity of VIA, 
could be due to large number of inflammatory lesion. Also majority 
of the cases were referred as VIA positive from other primary health 
centres.
The  high  NPV  of  both  VIA  and  VILI  warrants  particular 
mention.  The use of VIA / VILI as a primary screening test means 
that  women  assessed  as  test  negative  would  be  reassured  most 
probably that they do not have high grade CIN or Cancer cervix. 
With regards to VIA, VILI and cytology, the results were consistent 
with recent study findings of India and Africa which have shown 
VIA / VILI are more sensitive than cytology. (Sankaranarayanan et 
al, 2004a).
Abnormal pattern in both VIA and VILI were common among 
those  presented  with  abnormal  cytology.   One  Papsmear  positive 
case was missed by VIA.  VILI diagnosed all abnormal papsmear 
case.  The significant association of abnormal VIA and VILI with 
cytological abnormalities suggests that both tests have potential to 
detect abnormal cervical diseases.
                                         SUMMARY
The present study was conducted in the Department of O&G, 
GRH,  Madurai,  from September 2007 to October  2008 involving 
250 women.  They were screened with papsmear, VIA & VILI and 
those  positive  with  any  of  these  tests  were  subjected  to 
colposcopically directed biopsy cervix.  The sensitivity, specificity, 
PPV and NPV were calculated using biopsy report as the reference 
standard.
- The mean age of the study subjects and those with screen 
positivity were 32.44 yrs and 38.21 yrs respectively
- Majority (85.6%) of the CIN patients were in the age group 
of 35-45 years
- The mean age at marriage was 19.42 years and majority of 
them screened positive were multi para.
- One patient with IUCD had mild dysplasia
- Majority (64.2%)of the patients studied were permanently 
sterilized
Among those attending the OPD, white discharge was the 
predominant complaint.   Two patients with severe dysplasia 
gave H/o of post coital bleeding.
• Cervix  was  healthy  in  (21%)  of  the  patients  and 
unhealthy in rest of the patients. 
• 2.1%  of  the  patient  had  mild  dysplasia,  1.2%  of  the 
patients  had  moderate  and  severe  dysplasia.  Screen 
positivity rate for papsmear was 3.2%. 
• 30% of the patients had positive VIA.
• 25.2% of the patient were positive for VILI.
• Papsmear missed 2 cases of dysplasia and 
• VIA missed 1 case of dysplasia
The  sensitivity,  specificity,  PPV  &  NPV  of  VIA,  VILI, 
Papsmear are as follows.
VIA – 85.6%,   71.6%,     8%,       99.37%
VILI -  100.6%,  76.9%,  11.11%,  100%
Papsmear -  71.4%,   98.7%,   62.5%,    99.9%  respectively
Thus VIA, VILI were more sensitive than cytology.
However papsmear was more specific
As a single best, papsmear demonstrated the best balance of 
sensitivity and specificity and predictive value.
CONCLUSION
          In conclusion , as a single test ,cytology was  associated 
with the best balance of sensitivity, specificity and predictive 
values on the basis of our findings.
The significant association of abnormal VIA and VILI 
with  cytological  abnormalities  suggests  that  both  tests  have 
potential to detect abnormal cervical diseases.
The result of current study indicate that VIA and VILI 
are  simple  objective  test.   The  result  of  this  procedures  is 
available  immediately,  allowing  an  algorithm  of  further 
investigations  to  be  carried  out  for  the  identification  of 
cervical lesions.
VIA  & VILI  may  find  a  place  as  an  alternative  low 
technology  and  low  cost  methods  of  screening  and  case 
finding.  Further  research  is  required  to  improve  specificity 
without compromising sensitivity. 
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PROFORMA
SCREENING WITH VIA , VILI, PAPSMEAR
1.  Name : 2. OP / IP No. 3. Age
4.  Address :
5.  Education  :
6.  LMP : 7.  Marital status    
8.  Age at marriage / first sexual intercourse
9.  Total number of pregnancie / miscarriages
10. Do you suffer from the following ?
     Excessive  vaginal discharge Itching in the external genitalia
     Ulcer in the external genitalia Lower abdominal pain
     Pain during sexual intercourse Bleeding during intercourse
     Intermenstrual bleeding Low backache
11. Visual examination findings :
• Cervical polyp
• Nabothian follicles
• Erosion cervix
• Leukoplakia
• Condyloma
• Growth
12. Papsmear
13. VIA findings
  One minute after application of 5% acetic acid (VIA)
1.  Positive 2. Negative
14.   Findings after application of Lugol’s Iodine (VILI)
1.  Positive 2. Negative
15. Biopsy cervix  taken ?    1.  Yes     2.  No
MASTER CHART ABBREVIATIONS
SE Socio economic Status
PS Permanent sterilization
Pain abd. Pain Abdomen
White dis White discharge
Post coital bld Post coital bleeding
Hyper, con Hypertrophied, congested cervix
Nab. Cyst Nabothian cyst
Hyper, b/t Hypertrophied, bleeds on touch
Location of the squamocolumnar junction (SCJ) and 
transformation zone ; a) before menarche, b) after puberty and 
at early reproductive age  c)  in a woman in her 30s ; d) in a 
perimenopausal woman ; e) in a post menopausal woman.
     BEFORE APPLICATION OF LUGOL’S IODINE
VILI NEGATIVE
BEFORE APPLICATION OF ACETIC ACID
VIA POSITIVE
Normal squamous cells
A: superficial cells (arrows); B: intermediate cells; 
C: parabasal cells; D: metaplastic cells.
Low-grade Squamous Intraepithelial Lesion (LSIL)
LSIL: eosinophilic squamous cells with a perinuclear empty cavity surrounded  
by cytoplasmic thickening and with moderate nuclear enlargement: typical  
koilocytes.
HSIL
Parabasal cells with nuclear enlargement, irregular nuclear outlines, with  
anisokaryosis and anisocytosis in a homogenous
 cell population.
Squamous cell carcinoma
Group of moderately to poorly differentiated malignant cells, without  
keratinization








